STRO vs TSLA · rev $62.0M vs P/E 179, rev $94.83B
Sutro Biopharma (STRO) versus Tesla Inc (TSLA) — a side-by-side from cached financials, not a winner call.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Tesla Inc (TSLA) is a auto manufacturers company listed on US. It is led by Elon Musk.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
Latest reported TSLA revenue for 2025-12-31 was $94.83B. Net income was $3.79B. Revenue was down 2.9% from 2024-12-31 to 2025-12-31. TSLA currently screens at market cap $976.12B and trailing P/E 179.1.
STRO currently screens at market cap $470.8M. TSLA currently screens at market cap $976.12B and trailing P/E 179.1.
Not investment advice. Open the STRO and TSLA stock pages for the full models.
Not investment advice.